Objective: To evaluate the maternal and foetal outcome in cases of placenta previa, placenta accrete and placenta increta. Methods: Medical records of patients from 1 Feb 2014 to 28 Feb 2015 were checked and patients who underwent caesarean section with a diagnosis of placenta previa types III and IV (and placenta accreta, increta and percreta) were identified. Their medical record files were retrieved and data collected regarding patients age, parity, previous LSCS, D&C, blood loss, bladder injury, hysterectomy and use of B-lynch technique were recorded. Neonatal statistics were also recorded regarding birth weight, gender, APGAR score and need for admission in NICU. Results: In total 37 cases of major placenta previa were identified. These included 8 cases with placenta accrete including 2 cases of placenta increta. No maternal death occurred amongst the studied cases. Only one case of IUFD was identified. The incidence of placenta previa (major) was 29.95/1000 births. Average parity of patients with placenta accreta (PA) was significantly higher than cases of placenta previa (PP) (2.75 vs. 1.55, p = 0.04). Similarly average number of LSCS in cases of PA was significantly higher than cases of PP (2.25 vs. 0.86, p = 0.02). PA cases were delivered at a significantly earlier gestational age as compared to cases with PP (34.5 weeks vs. 37 weeks, p = 0.01). Hysterectomy was done in 6 (75%) cases of PA but in none with PP. Bladder injury occurred in 2(25%) cases of PA but in none with PP. Blood loss was also significantly higher in PA cases than PP cases (3975 ml vs. 1196 ml, p = 0.006). Conclusion: At tertiary care hospitals, maternal and foetal outcomes for placenta previa and placenta accreta have improved owing to improved surgical techniques and better understanding of these conditions.
Introduction
Placentaprevia (PP) is the presence of placental tissue which extends over or lies very close to the internal cervical os. Prevalence of placenta previa has been reported in the range of 3.5 to 4.6 per 1000 births. 1 Prevalence of PP is rising as a result of increasing rates of LSCS. 2 New research on abnormal placentation suggests individualised approach to improve delivery timing. 3 Risk factors for PP include previous PP, previous LSCS, multiple gestation, multiparity, advanced maternal age, previous abortion, previous intrauterine surgical procedure, male foetus and non-white race. Placenta previa has historically been associated with severe complications like ante partum, intra-partum and postpartum haemorrhages, which often nece-ssitate blood transfusion and/or hysterectomy. Maternal morbidity and mortality in cases of PP has been reported to be high in resource-poor countries. 4 Placenta accreta (PA) is the implantation of placenta where anchoring placental villi attach to myometrium rather than decidua. In placenta increta the villi penetrate the myometrium and in placenta percreta they penetrate through myometrium to the serosa. PA and other forms of morbidly attached placenta are mostly found in association with PP. In this article the term placenta previa refers to PP without morbid placental attachment whereas PA is used for placenta attached to or penetrating the myometrium.
It has been reported that neonatal outcomes associated with PP have improved due to improved obstetric management, and better neonatal care. We hypothesised that foetal and maternal outcomes in cases of placenta previa, accreta and increta have improved due to advancements in obstetric care in the present times. Objective of our study was to test if this hypothesis was correct. We retrospectively studied cases of PP and PA who presented at Hameed Latif Hospital during the period from Feb 2014 to Feb 2015 and report the findings here.
Patients and Methods
It was a retrospective study which was carried out in Hameed Latif Hospital, Lahore Pakistan. Hameed Latif Hospital is a 250 bedded private sector tertiary care hospital and is a centre of excellence for gynaecology and obstetrics in the region. After obtaining approval from the hospital ethical committee, hospital records from 1 Feb 2014 to 28 Feb 2015 were checked. All patients who underwent caesarean section due to PP or PA were included in the study. Their medical record files were retrieved and data were collected regarding date of presentation, stage of pregnancy, obstetric history, type of placenta previa, emergency or elective caesarean section and amount of blood loss during the surgery. Blood loss had been calculated from the number of gauze pads soaked with blood during the surgery. Note was also made if any bladder injury had occurred during the surgery and if B-lynch technique was used to stop bleeding and save uterus. Data pertaining to baby including gender, birth weight, APGAR score at 1 and 5 min and need for admission to NICU were also recorded. Data were then analysed using MS Excel 2010. P value ≤0.05 was taken as statistically significant at 95% confidence interval.
Results
Total 37 patients were enrolled in the study. Placenta previa type III was diagnosed in 16 (43.3%) patients and type IV in 21 (56.7%) patients. Eight (21.6%) patients (all with previa type IV) had placenta accreta including two with placenta increta. Total number of patients delivered during the study period was 1235 which gives us the incidence of placenta previa major as 29.95/1000 births. Mean age of the patients was 31.37 (24 -42) years, mean age for previa (PP) patients without accreta was 31.17 (SD ± 4.36) years and mean age for PA was 32.12 (SD ± 4.05) years. Women with PA had higher average parity than those with PP (2.75 vs. 1.55) (p = 0.04). Eighty seven percent patients with PA had had one or more LSCS and mean number of LSCS that these patients had was 2.25. This is in contrast with corresponding figures for PP without PA where 48% patients had had LSCS before. Average number of LSCS in patients with PP without PA was 0.86.When mean number of LSCS between PP and PA were compared, the difference was found statistically significant (p = 0.02). Mean gestational age at the time of LSCS was significantly less in PA as compared to PP (34.5 vs. 37 weeks p = 0.01). Caesarean hysterectomy was performed in 6 cases of PA but in none of the cases with PP without PA (p = 0.001). Bladder injury was noted in 2 patients with PA but in none with PP without PA (p = 0.08). B-lynch technique was used in 2 cases of placenta accreta to stop haemorrhage and hysterectomy was successfully avoided in both these patients. B-lynch was used in 2 cases of PP without accreta and hysterectomy was avoided in these two as well. Hysterectomy was performed in both cases of placenta increta. Hysterectomy was also performed in both cases of PA in which bladder injury occurred.
Two (25%) patients with PA underwent LSCS before 32 weeks gestation while Four (50%) had LS-CS between 33 and 37 weeks gestation and another 2 (25%) reached term before LSCS. Most (22, 75.8%) patients with PP had LSCS at or after 37 weeks gestation while 7 (24.2%) were delivered between 33 and 37 weeks. None of the patients with PP delivered before 32 weeks gestation.
Thirty nine foetuses were delivered (there were two twin pregnancies). There was one intra-uterine foetal demise (IUFD). Ratio of female to male foetus in PP was 18:13 (1:0.72) while in PA it was 3:5 
Discussion
In present study preterm LSCS (before 37 weeks) was done in 24.13% of women with PP which is higher 299 than overall average of preterm deliveries (11% to 18%). 5 No caesarean hysterectomy was performed for 29 cases of PP. This is in sharp contrast with some of the previously reported figures for hysterectomy rates in PP. 6 It is perhaps a result of early diagnosis and cautious management of PP during pregnancy and LSCS. In a study by Dola et al 7 published in 2003, the authors reported around 20% caesarean hysterectomy for PP type IV. Over the past 2 decades obstetricians seem to have improved significantly in terms of carrying the pregnancy as close to term as possible in order to achieve foetal maturity.
Figures for preterm caesarean delivery were also surprisingly low in our study. About one fourth (24.13%) of total patients underwent LSCS before 37 weeks which is in contrast to the figures reported in past. Mcshane et al 8 in their study published in 1985 reported that 66.6% of cases with PP were delivered before 36 weeks gestation despite best available management at that time.
Average blood loss in cases of major placenta previa has been reported in the range of 1500 -1600 ml. 9, 10 Average blood loss in present study (1196 ml) is lower than these earlier studies again reflecting an improvement in maternal outcomes.
Thirty nine babies were delivered in total (two were twin pregnancies). There was only one IUFD and it was an anomalous baby. This is a significantly better neonatal outcome as old studies reported much worse outcomes for neonates with peri-natal mortality reaching as high as 37%. 11 A study carried out at Sheikh Zayed post graduate institute Lahore in 2004 to 2007 reported neonatal mortality rate of 14% for placenta previa patients. 12 Peri-natal mortality in PP cases has been variously reported from 2.3% 13 to 50%. 14 In the same study maternal mortality was 2%. In another study carried out at civil Hospital Karachi, published in 2010 reported 23.38% early neonatal mortality in cases of placentaprevia. 15 Other complications associated with PP including respiratory distress syndrome, major congenital anomalies were not seen in present study.
An alternative approach for management of PA by conservative method was suggested and tested in a multicenter French study by Sentilhes et al. 16 Placenta was left in situ in expectation that spontaneous resorption of placenta would follow naturally. This treatment approach was successful in 78% patients whereas 21.6% patients had either primary or delayed hysterectomy. A study by Read et al reported a caesarean hysterectomy rate of 63.63% for cases with PA. 17 This approach was also recommended based on a large descriptive study in UK reported by Fitzpatrick et al. The study concluded that women who have no attempt to remove their placenta for conserving uterus have reduced levels of haemorrhage and reduced need for blood transfusion.
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Conclusion
Present study suggests that in tertiary care centres in Pakistan, maternal and foetal outcomes for pregnancies with major placenta previa (type III and IV) are not as poor as previously reported but morbidity is significantly increased if placenta previa is also complicated by placenta accerta or increta.
